New York State Common Retirement Fund Graphite Bio, Inc. Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$2.24 - $2.66 $123 - $146	-55 Reduced 0.15%	36,530 $96,000
Q3 2023 Nov 07, 2023	BUY	$2.18 - $2.77 $621 - $789	285 Added 0.79%	36,585 $91,000
Q2 2023 Aug 07, 2023	BUY	$2.47 - $3.38 $89,661 - $122,694	36,300 New	36,300 $94,000
Q2 2022 Aug 04, 2022	SELL	$2.14 - $5.23 $50,825 - $124,212	-23,750 Reduced 98.79%	290 $1,000
Q1 2022 May 05, 2022	BUY	$5.1 - $13.06 $92,820 - $237,692	18,200 Added 311.64%	24,040 $123,000
Q4 2021 Feb 02, 2022	BUY	$8.41 - $16.71 $1,177 - $2,339	140 Added 2.46%	5,840 $73,000
Q3 2021 Nov 02, 2021	BUY	$15.81 - $28.39 $90,117 - $161,823	5,700 New	5,700 $93,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.